Ashish Upadhyay (@asupadh) 's Twitter Profile
Ashish Upadhyay

@asupadh

Nephrology Program Director @bu_bmc_renal ; Associate Professor @BUMedicine; #EBM; #MedEd; Views all mine 🇳🇵🇺🇸🎸👨‍👩‍👧‍👦

ID: 1113089210217648128

linkhttp://bumc.bu.edu/nephrology/ calendar_today02-04-2019 14:42:02

710 Tweet

504 Followers

303 Following

BU/BMC Section of Nephrology (@bu_bmc_renal) 's Twitter Profile Photo

Honored to highlight Late breaking clinical trial American Society of Nephrology #kidneyweek2024 and NEJM paper from Gbadegesin Lab and #H3AfricaKDRN. We congratulate titi ilori on her collaborative work on this landmark paper advancing the understanding of #APOL1 mediated kidney disease.

Honored to highlight Late breaking clinical trial <a href="/ASNKidney/">American Society of Nephrology</a> #kidneyweek2024 and <a href="/NEJM/">NEJM</a> paper from <a href="/GbadegesinLab/">Gbadegesin Lab</a> and #H3AfricaKDRN. 
We congratulate <a href="/ilori_titi/">titi ilori</a> on her collaborative work on this landmark paper advancing the understanding of #APOL1 mediated kidney disease.
Sam Kant (@kantsmd) 's Twitter Profile Photo

The Nephrology Board Review & Certification Exams Edition (Part 1)- high yield content for exams not only in the US but also worldwide (in addition to being pertinent clinically). Contents below AKDH NKF Nephrology Professionals Charuhas V Thakar Jeffrey William St Vincent's University Hospital (SVUH) sciencedirect.com/journal/advanc…

BU/BMC Section of Nephrology (@bu_bmc_renal) 's Twitter Profile Photo

BMC Section of Nephrology kicked off the New Year on the basketball court, celebrating accomplishments and reflecting on a year of growth! Here’s to more wins ahead!

BMC Section of Nephrology kicked off the New Year on the basketball court, celebrating accomplishments and reflecting on a year of growth! Here’s to more wins ahead!
Ashish Verma, MD (@ashunephro) 's Twitter Profile Photo

Thrilled to share our publication led by exceptional Sophie Claudel, MD "Cumulative Incidence of Mortality Associated with Cardiovascular-Kidney-Metabolic Syndrome"journals.lww.com/jasn/abstract/… in #JASN ASN Publications . We report relative and absolute risk by each CKM stages #CKM

Thrilled to share our publication led by exceptional <a href="/SophieClaudel/">Sophie Claudel, MD</a> "Cumulative Incidence of Mortality Associated with Cardiovascular-Kidney-Metabolic Syndrome"journals.lww.com/jasn/abstract/…  in #JASN <a href="/asnpublications/">ASN Publications</a> . We report relative 
 and absolute risk by each CKM stages #CKM
AJKD (@ajkdonline) 's Twitter Profile Photo

Quiz: Young man with 1 week of fever, headaches, nonproductive cough, 1 day of dyspnea. Within 36 hours, he had 1 episode of hemoptysis and worsening hypoxia requiring mechanical ventilation. bit.ly/3QvWcGC (FREE) Joyita Bharati MikeBaldino Ashish Upadhyay BU/BMC Section of Nephrology

Quiz: Young man with 1 week of fever, headaches, nonproductive cough, 1 day of dyspnea. Within 36 hours, he had 1 episode of hemoptysis and worsening hypoxia requiring mechanical ventilation. 

bit.ly/3QvWcGC (FREE)

<a href="/Joyita_4/">Joyita Bharati</a> <a href="/MikeBaldino90/">MikeBaldino</a> <a href="/asupadh/">Ashish Upadhyay</a> <a href="/bu_bmc_renal/">BU/BMC Section of Nephrology</a>
David Sinclair (@davidasinclair) 's Twitter Profile Photo

Medicines that cause glucose expulsion in urine called SGLT2 inhibitors are putative longevity drugs. They also prevent aortic stenosis, but how? New pre-print says it's SIRT1 in the valve cells, pointing to SIRT1 activators & NAD precursors as therapeutics 🧵

Daniel Coyne (@drdanmo) 's Twitter Profile Photo

Fascinating read… Drugs Have Uses We Can’t Imagine. He’s Using A.I. to Find Them. - The New York Times archive.is/2025.03.20-153…

BU/BMC Section of Nephrology (@bu_bmc_renal) 's Twitter Profile Photo

Thought-provoking read on the evolving landscape of IgA Nephropathy trials and the authors views on challenges and opportunities in the Membranous Nephropathy space.👇 Guest editorial by Joyita Bharati and Laurence H Beck, Jr on #nephsap ASN Publications doi.org/10.58483/nsap.…

Rajiv Agarwal MD, MS (@agarwalrajivmd) 's Twitter Profile Photo

More than 50% reduction in uacr with combo and about 30% with each component that is empagliflozin and finerenone. Time to consider simultaneous initiation of combination therapy in ckd and t2d as in hfref and stage 2 hypertension.